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Simple Summary: Dietary chromium has been shown to reduce fat deposition and improve insulin
action whereas dietary fat can increase fat deposition and cause insulin resistance. This study found
that dietary nanoparticles of chromium picolinate, an organic form of chromium, caused changes in
the genes involved in insulin action in both muscle and fat tissue that indicated improved insulin
action. Conversely, a moderate increase in dietary fat caused changes consistent with increased fat
deposition and reduced insulin action. In conclusion, nanoparticles of chromium picolinate offer a
means of supplementing pigs diets to improve growth performance and carcass composition.
Abstract: The aim of this study was to investigate the interactive effects of dietary nano chromium
picolinate (nCrPic) and dietary fat on genes involved in insulin signaling in skeletal muscle and
subcutaneous adipose tissue of pigs. Forty-eight gilts were stratified on body weight into four
blocks of four pens of three pigs and then within each block each pen was randomly allocated to
four treatment groups in a 2 × 2 factorial design. The respective factors were dietary fat (22 or
57 g/kg) and dietary nCrPic (0 or 400 ppb nCrPic) fed for six weeks. Skeletal muscle samples were
collected from the Longissimus thoracis and subcutaneous adipose tissue collected from above this
muscle. Dietary nCrPic increased adiponectin, uncoupling protein 3 (UCP3) and serine/threonine
protein kinase (AKT) mRNA expression, whereas dietary fat decreased adiponectin and increased
leptin, tumor necrosis factor-α (TNF-α), peroxisome proliferator-activated receptors γ (PPARγ) and
CCAAT/enhancer-binding protein α (C/EBPα) mRNA expression in adipose tissue. In skeletal muscle,
dietary nCrPic increased phosphatidylinositol 3 kinase (PI3K), AKT, UCP3 and interleukin-15 (IL-15),
as well as decreased suppressor of cytokine signaling 3 (SOCS3) mRNA expression. The improvement
in insulin signaling and muscle mass and the reduction in carcass fatness by dietary nCrPic may be
via decreased SOCS3 and increased UCP3 and IL-15 in skeletal muscle and increased adiponectin in
subcutaneous adipose tissue.
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1. Introduction
The rapid rise in obesity is a critically important health issue worldwide. Obesity is associated with
a number of health problems including the development of insulin resistance. Obesity is characterized
by increased storage of fatty acids in an expanded adipose tissue mass and is closely associated with the
development of insulin resistance in peripheral tissues such as skeletal muscle and adipose tissue [1].
High dietary fat intake has been implicated as a major cause of insulin resistance with several studies
demonstrating an association between high-fat feeding and insulin resistance, suggesting a causal role
of dietary fat in the pathophysiology of type 2 diabetes [2–4].
Although the molecular mechanisms leading to insulin resistance remain elusive, emerging
evidence suggests that a high fat mass or the rate of fat deposition is strongly correlated with insulin
resistance [5–7]. The transcriptional factors peroxisome proliferator-activated receptors (PPARs), C/EPB
and sterol regulatory element-binding proteins (SREBPs) play important roles in adipogenesis [8].
For example, the expression of C/EBPs has been shown to induce the expression of PPARγ during an
early stage of adipocyte differentiation in vitro [9]. Expression of PPARγ in adipose tissue promotes
the differentiation of preadipocytes and regulates some fat cell-specific genes expression [10]. SREBPs
modulate lipogenesis and cholesterol homeostasis and SREBP2 overexpression increases fatty acid
syntheses (FAS) gene expression [11].
Adipose tissue is now recognized as an endocrine organ that contributes to insulin resistance [12].
In the past decade, a large number of endocrine and inflammatory pathways have been shown to be
dysregulated in obesity [5]. Adipokines produced by adipose tissue have been identified as potential
contributors to insulin resistance [12]. The representative adipokines produced by adipose tissue
include leptin, adiponectin and TNF-α. Dysregulated production of these adipokines is involved in the
pathogenesis of the obesity-associated metabolic syndrome. For example, overexpression of TNF-α
from accumulated fat contributes to the development of insulin resistance in obesity [13]. In contrast,
adiponectin is down-regulated in obesity and improves insulin sensitivity [14]. Leptin has been shown
to result in increased insulin sensitivity via increased fatty acid β-oxidation. However, high-fat diets or
development of obesity may lead to leptin resistance in skeletal muscle [15–17].
Chromium (Cr) is an essential mineral element in both humans and animals [18,19] with trivalent
Cr being the most stable form occurring in nature. Cr functions as a cofactor for the hormone insulin
and enhances the ability of insulin to regulate glucose, protein and fat metabolism [20]. A dietary
deficiency of Cr is believed to be positively associated with the risk of diabetes [21] and obesity [22].
Accordingly, several human and animal studies have demonstrated that exogenous Cr administration
improves glucose tolerance and insulin sensitivity in type 2 diabetes and obesity [23–25]. The interest
in Cr supplementation during the finisher phase of pig production is primarily for its potential impact
to improve body composition. However, the effect of Cr on body composition of finisher pigs is
inconsistent. Some of the variation in response to Cr may be related to the low absorption and
availability of Cr, and there is potential to improve this by reducing the particle size of Cr.
The present study evaluated the effect of dietary nano chromium picolinate (nCrPic) and fat on
adipogenesis and insulin signaling using the pig as a biomedical model. Furthermore, in an attempt to
understand the potential molecular mechanisms involved, the effect of dietary nCrPic and fat on genes
associated with adipokines and insulin resistance was investigated.
2. Materials and Methods
The procedures used in the experiment were approved by The University of Melbourne, School of
Land and Environment Animal Ethics Committee (permit number: Ethics ID: 0810919.1).
2.1. Animals and Treatments
The tissue samples used for quantifying mRNA expression in this investigation were obtained
from a subset of animals used in a previous experiment [26]. In brief, forty-eight Large white and
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Landrace cross breed finishing gilts (PrimeGro™ Genetics, Rivalea Pty Ltd. Corowa, NSW, Australia)
with and initial weight 52.2 ± 7.3 kg were stratified on weight into four blocks of four pens of three pigs
and then within each block each pen was randomly allocated to four treatment groups in a 2× 2 factorial
design. The respective factors were dietary fat (22 or 57 g/kg) and dietary Cr (0 or 400 ppb nCrPic)
fed for six weeks. The iso-nitrogenous (160 g/kg crude protein and 9 g/kg total lysine) and iso-caloric
(13.8 megajouledigestible energy/kg) diets were based on wheat and wheat byproducts, soybean meal
and meat meal with additional fat in the high-fat diet provided by tallow. The nCrPic particles were
prepared as described previously [26]. Briefly, the raw CrPic material was ground and then passed
through an appropriate-sized end-plate sieve, the particle sizes was 49.7 ± 12.37 nm (mean ± s.d.).
The microstructure image of nCrPic is shown in Figure 1. The microstructure of the nCrPic was
examined by a transmission electronic microscope (TEM) (Hitachi, H-7100, Japan) equipped with a
link energy dispersive spectroscopy system and using a bean energy of 300 KeV. For the TEM study,
the washed powder was dispersed in methanol using an ultrasonic bath, and a drop of suspension
was placed on a copper grid coated with holey carbon film.
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2.4. RNA Extraction and Quantification 
Standard techniques were used. Briefly, the total RNA extraction was undertaken using the 
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2.2. Blood Sampling and Plasma Analyses
Blood samples from the median weight pig in each pen were collected via venepuncture from
the anterior vena cava at the end of the experiment and after a 16 h fast. After collection of blood,
the samples were placed on ice for 1 h, and then centrifuged for 15 min at 1500 g. Plasma was collected
and frozen (20 ◦C) until subsequent analysis for glucose and insulin concentrations to determine the
degree of i sulin resistance using the homeostatic model a sessment (HOMA) method [27]. Plasma
insulin concentrations were determined by radio mmunoassay (Millipore, Billerica, MA, USA) while
plasma glucose was determined by an enzymatic colorimetric procedure (Thermo Fisher Scientific,
Waltham, MA, USA).
2.3. Subcutaneous Adipose and Skeletal Muscle Biopsies Collection
All pigs were slaughtered commercially after being fed dietary treatments for six weeks (mean
body weight 91.5 ± 10.3 kg). After slaughter, all carcasses were ultrasonically scanned (Pork Scan,
Brisbane, Qld, Australia) at the P2 site (65 mm from midline over the last rib) for determination
of backfat and muscle depth at the P2 site. Subcutaneous adipose tissue sample from above the
Longissmus thoracis and skelet l muscle tissue amples from Longissmus thoracis were collected from
the median weight pig in each pen within 25 min post-slaughter and frozen in liquid nitrogen before
preservation at −80 ◦C for batched gene expression studies.
2.4. RNA Extraction and Quantification
Standard techniques were used. Briefly, the total RNA extraction was undertaken using
the PureLink™ Micro-to-Midi Total RNA Purification System (Invitrogen, Carlsbad, CA, USA).
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The PureLink™DNase kit (Invitrogen) was then used to remove genomic DNA. The integrity of RNA
was assessed via agarose gel electrophoresis via the Experion automated electrophoresis station and the
Experion StdSens Analysis kit according to the manufacturer’s instructions (Bio-Rad Laboratories Inc.,
Hercules, CA, USA), and total RNA was quantified using a spectrophotometer (Nanodrop ND-1000,
Thermo Fisher Scientific, Newark, DE, Waltham, MA, USA) with readings taken at 260 and 280 nm.
2.5. Reverse Transcriptase PCR and Real-Time Quantitative-PCR (Q-PCR)
Primer optimum annealing conditions were determined and are given in detail in the Table 1.
Extracted RNA was transcribed to complimentary DNA (cDNA) using the SuperScript III First-Strand
Synthesis System for RT-PCR (Invitrogen, USA) according to the manufacturer’s instructions.
A LightCycler 480 II (Roche Diagnostics) was used for Q-PCR analysis. Each Q-PCR reaction
mix consisted of 4 µL of SYBR Green 1 Master (Roche Diagnostics, Basel, Switzerland), 1 µL of forward
primer, 1 µL of reverse primer, 1 µL of cDNA, and 3 µL of RNase free water. The following thermal
cycling protocol was followed: 1 cycle of pre-denaturation (95 ◦C for 10 min), followed by 40 cycles of
amplification (95 ◦C for 10 s, 57–63 ◦C for 10 s (dependent on primer), 72 ◦C for 10 s), 1 cycle of melting
(95 ◦C for 5 s, 65 ◦C was then used to remove genomic DNA for 1 min, 97 ◦C for continuous analysis),
and cooling (40 ◦C for 30 s). Changes in gene expression were calculated as 2−∆Ct, where Ct represents
the cycle in which fluorescence threshold is reached and
∆Ct = Ct target gene − Ct housekeeping gene (1)
with β-actin utilized as a standard housekeeping gene.
Table 1. List of primers used for pig tissue gene expression.
Gene AccessionNumber Primer Sequence
Annealing
Temp. (◦C)
Amplicon
Size (bp) GC%
β-actin DQ845171 For 5
′ACATCCGCAAGGACCTCTAC3′
Rev 5′ACATCTGCTGGAAGGTGGAC3′
56.5
56.9 210
55
55
Insulin receptor XM003123154.3 For 5
′CAACACTGGTGGTGATGGAG3′
Rev 5′CCATCCCATCAGCAATCTCT3′
52.7
51.2 150
55
50
PI3K NM213939 For 5
′AACCTCCAGATCTACTGCGGCAAA3′
Rev5′AGGAAGCGGTGGTCTATCAGCAAT3′
60.1
60.0 134
50
50
AKT NM001159776 For 5
′TTCTACAACCAGGACCACGA3′
Rev 5′AATACCTGGTGTCCGTCTCG3′
52.4
53.4 268
50
50
GLUT4 NM001128433 For 5
′GTCCAACTTCATCATCGGCA3′
Rev 5′ATGAAGAAGCCAAGCAGGAG3′
52.5
52.0 99
50
50
PPARγ AB097926 For 5
′CTTTATGGAGCCCAAGTTCG3′
Rev 5′GAGGACTCTGGGTGGTTCAA3
50.8
53.0 200
50
55
C/EBPα AF103944 For 5
′GCTGACCAGTGACAATGACC3′
Rev 5′GGCACCGGAATCTCCTAGTC3′
55.4
58.8 250
55
60
SREBP-1 AY338729 For 5
′TCCTTCCACCATGAGCTCCC3′
Rev 5′CACCGACGGGTACATCTTCA3′
55.3
53.7 118
60
55
JNK1 XM003359272.1 For 5
′ACCTGACAAGCAGTTGGATG3′
Rev 5′TAGTCATCTACAGCAGCCCA3′
56.0
56.5 238
50
50
FAS AY183428 For 5
′TCGTGGGCTACAGCATGATA3′
Rev 5′GGAGTTAGGCTTCAGCAGGA3′
57.3
57.0 208
50
55
IL-15 NM214390 For 5
′CAACCTGGCAGCACGTAAT3′
Rev5′CAGGAGAAAGCACTTCATCGCTGT3′
52.5
57.5 137
50
50
UCP3 NM214049 For 5
′ACACAGATGTCCAGAGGTCA3′
Rev 5′CCAAACTCCACACCCTTCAA3′
58.0
57.9 182
50
50
SOCS3 AY944571 For 5
′CTGGCTCTTTGATTTGGTTT3′
Rev 5′TGGACTCTGGGACCTGTATT3′
54.7
54.0 280
40
50
Adiponectin EF601160 For 5
′CTTGCGGGTCCTTGATAAAT3′
Rev 5′CCCCTAACCTCAGTGGAAAA3′
50.0
50.8 192
45
50
Leptin NM213840 For 5
′CCTCTGAATGGTCTGGGTTG3′
Rev 5′GGACTTGGGACCATCTGCTA3′
57.4
57.2 182
55
55
TNF-α NM214022 For 5
′CTGCCTTGGTTCAGATGTGT3′
Rev 5′CAGCGATGTAGCGACAAGTT3′
52.3
53.0 172
50
50
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2.6. Statistical Analyses
All gene expression data were analysed as the threshold cycle (cT) relative to that of the
housekeeping gene β-actin (∆CT) and assessed for main and interactive effects of dietary fat and nCrPic
by ANOVA and within a tissue by multiple ANOVA (MANOVA) that included all genes analysed
within each tissue. A difference in ∆CT of −1.0 is associated with a doubling (200%) and + 1.0 a halving
(50%) of expression and for ease of presentation data are presented as % relative to expression in tissue
from gilts fed the control diet without supplemental fat or nCrPic. This form of presentation does
not allow for the presentation of error bars although error terms can be found in the supplemental
tables. Data are presented graphically in the manuscript and tabulated in supplementary Table S1
(adipose tissue) and Table S2 (skeletal muscle). In addition, correlations have been conducted between
all mRNA expressions (as ∆Ct) as well as with the phenotypic measures of HOMA, back fat depth, loin
muscle depth and carcass weight. These correlation coefficients are to be found in a supplemental table
(Table S3). All statistical analysis were conducted using GENSTAT (16th edition, Hemel Hempstead,
UK). A value of p < 0.05 was used to indicate statistical significance and p < 0.10 to indicate a trend.
3. Results
3.1. Carcass Composition and Plasma Homeostatic Model Assessment of Insulin Resistance
The growth performance and carcass characteristics have been reported elsewhere [26] but in
order to relate the gene expression data to the physiological state of the pigs, some of the data are
presented in brief here. Dietary nCrPic increased the size of the Longissmus thoracis muscle as indicated
by muscle depth (49.0 vs. 53.6 mm, standard error of difference (s.e.d.) = 1.13 mm, p = 0.004) and
decreased the subcutaneous fat thickness (8.2 vs. 7.4 mm, s.e.d. = 0.24 mm, p = 0.018). While there
were no main effects of dietary fat there were interactions between dietary nCrPic and fat for muscle
depth (p = 0.019) and fat depth (p = 0.042) such that the effects of nCrPic were most pronounced in pigs
fed the high-fat diet. Insulin resistance as determined using the homeostatic model assessment was
decreased by dietary nCrPic (1.25 vs. 0.66, s.e.d. = 0.147, p = 0.009).
3.2. Adiponectin, Leptin, TNFα and c-Jun N-Terminal Kinase (JNK1) Gene Expression in Porcine Adipose Tissue
The expression of subcutaneous adipose tissue leptin was doubled by the high-fat diet (relative
expression was 210 and 441% for main effects of low- and high-fat diets, respectively, (p = 0.036).
However, there was also an interaction (p = 0.040) between dietary fat and nCrPic such that adipose
tissue leptin mRNA expression was increased around 5.5 fold by the high-fat diet alone but not when
dietary nCrPic was fed (Figure 2). Similarly, the expression of TNFα in adipose tissue tended to be
higher in pigs fed the high-fat diet (relative expression was 86 and 141% for main effects of low- and
high-fat diets respectively, p = 0.10). However, there were no statistical differences in the expression
of leptin mRNA (p = 0.39) and TNF-α mRNA (p = 0.23) between pigs fed nCrPic and their controls.
The expression of adiponectin in adipose tissue was higher in pigs fed the high-fat diet (relative
expression was 105 and 75% for main effects of low- and high-fat diets, respectively, p = 0.016) and
lower in the nCrPic treatment group (relative expression was 80% and 100% for main effects of control
and nCrPic diets, respectively, p = 0.067). The expression of mitogen-activated protein kinase-8 JNK1
was increased by the high-fat diet with the relative expression being 175% of the low-fat diet (p = 0.032).
There was no effect of dietary nCrPic on expression of JNK1.
Animals 2020, 10, 1685 6 of 14
Animals 2020, 10, x 6 of 14 
 
 
Figure 2. Leptin, adiponectin, tumor necrosis factor α (TNFα), peroxisome proliferator-activated 
receptor γ (PPARγ), CCAAT enhancer binding protein α (C/EBPα), sterol regulatory element-binding 
protein (SREBP), fatty acid synthase (FAS) and mitogen-activated protein kinase-8 (JNK1) mRNA 
expression in subcutaneous adipose tissue from gilts fed with nCrPic with or without a high-fat diet. 
All gene expression data were analysed as the threshold cycle (cT) relative to that of β-actin (∆CT) 
and assessed for main and interactive effects of dietary fat and nCrPic by ANOVA. A difference in 
∆CT of −1.0 is associated with a doubling (200%) and +1.0 a halving (50%) of expression and for ease 
of presentation data are presented as % relative to expression in tissue from gilts fed the control diet 
without supplemental fat or nCrPic. This method of presentation prevents the presentation of the 
error term. 
3.3. PPARγ, C/EBPα, SREBP and FAS Gene Expression in Porcine Adipose Tissue 
The expression of PPARγ (relative expression was 89%and 180% for main effects of low- and 
high-fat diets respectively, p = 0.058) and C/EBPα (relative expression was 136% and 356% for main 
effects of low- and high-fat diets respectively, p = 0.017) were higher in adipose tissue from pigs fed 
high-fat diets. On the other hand, there were no main effects of dietary nCrPic on the adipose tissue 
expression of PPARγ, C/EBPα, SREBP and FAS (Figure 2). There were no significant effects of dietary 
fat or nCrPic on the expression of SREBP and fatty acid synthase in porcine adipose tissue (Figure 2).  
3.4. IR, PI3K, AKT, UCP3 and SOCS3 Gene Expression in Porcine Adipose Tissue 
The expression of the insulin signaling pathway gene AKT was higher in pigs fed the nCrPic 
diet (relative expression was 103 and 186% for main effects of control and nCrPic diet, respectively, 
p = 0.026) (Figure 3). However, dietary nCrPic had no effect on adipose tissue IR (p = 0.91) and 
phosphatidylinositol 3 kinase (PI3K) (p = 0.59) mRNA expression. The expression of the UCP3 gene 
in adipose tissue was higher in pigs fed dietary nCrPic (relative expression was 191 and 431% for 
main effects of control and nCrPic diets, respectively, p = 0.003) and lower in pigs fed the high-fat diet 
(relative expression was 242 and 381% for low- and high-fat diets, respectively, p = 0.021).There was 
no effect of either dietary fat or nCrPic on suppressor of cytokine signaling 3 (SOCS3) or GLUT4 gene 
expression (Figure 3). 
Figure 2. Leptin, adiponectin, tumor necrosis factor α (TNFα), peroxisome proliferator-activated
receptor γ (PPARγ), CCAAT enhancer binding protein α (C/EBPα), sterol regulatory element-binding
protein (SREBP), fatty acid synthase (FAS) and mitogen-activated protein kinase-8 (JNK1) mRNA
expression in subcutaneous adipose tissue from gilts fed with nCrPic with or without a high-fat diet.
All gene expression data were analysed as the threshold cycle (cT) relative to that of β-actin (∆CT)
and assessed for main and interactive effects of dietary fat and nCrPic by ANOVA. A difference in
∆CT of −1.0 is associated with a doubling (200%) and +1.0 a halving (50%) of expression and for ease
of presentation data are presented as % relative to expression in tissue from gilts fed the control diet
without supplemental fat or nCrPic. This method of presentation prevents the presentation of the
error term.
3.3. PPARγ, C/EBPα, SREBP and FAS Gene Expression in Porcine Adipose Tissue
The expression of PPARγ (relative expression was 89%and 180% for main effects of low- and
high-fat diets respectively, p = 0.058) and C/EBPα (relative expression was 136% and 356% for main
effects of low- and high-fat diets respectively, p = 0.017) w re higher in adipose tissue fro pigs fed
high-fat diets. On the other hand, th re were no main ffects of dietary nCrPic on the adipose tissue
expres ion of PPARγ, C/EBPα, SREBP and FAS (Figure 2). There were no signific nt effects of dietary
fat or nCr ic on the expression of SREBP and fatty acid synthase in porcine adipose tissue (Figure 2).
3.4. IR, PI3K, AKT, UCP3 and SOCS3 Gene Expression in Porcine Adipose Tissue
The expression of the insulin signaling pathway gene AKT was higher in pigs fed the nCrPic
di t (relative expression was 103 nd 186% for mai effects of control and nCrPic diet, respectively,
p = 0.026) (Figure 3). However, dietary nCrPic had no effect on adipose tissue IR (p = 0.91) and
phosphatidylinosit l 3 kinase (PI3K) (p = 0.59) mRNA expression. The expression of the UCP3 gene
in adipose tissue was higher in igs fed dietary nCrPic (relative expression was 191 and 431% for
main effects of control and nCrPic iets, respectively, p = 0.003) and lower in pigs fed the high-fat diet
(relative expressio was 242 and 381% for low- and high-fat diets, r spectively, p = 0.021).There was no
effect of either dietary fat or nCrPic on suppressor of cytokin signaling 3 (SOCS3) or GLUT4 gene
xpression (Figure 3).
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Figure 3. Phosphatidylinositol 3 kinase (PI3K), protein kinase B (AKT), uncoupling protein 3 (UCP3),
suppressor of cytokine signaling 3 (S CS3), glucose transporter 4 (GLUT4) and insulin receptor (IRS)
expression in subcutaneous adipose tissue from gilts fed with nCrPic with or without a high-fat
diet. All gene expression data were analysed as the threshold cycle (cT) relative to that of β-actin (∆CT)
and assessed for main and interactive effects of dietary fat and nCrPic by ANOVA. difference in
∆CT of −1.0 is associated with a doubling (200%) and +1.0 a halving (50%) of expression and for ease
of presentation data are presented as % relative to expression in tissue from gilts fed the control diet
without supplemental fat or nCrPic. This method of presentation prevents the presentation of the
error term.
3.5. IR, PI3K, AKT, GLUT4 and SOCS3 Gene Expression in Porcine Skeletal Muscle Tissue
The expression of IR, PI3K, AKT, GLUT4 and SOCS3 mRNA expression in porcine skeletal muscle
tissue in response to dietary nCrPic and fat are shown in Figure 4. Dietary nCrPic up-regulated the
expression of skeletal muscle tissue insulin signaling pathway gene PI3K (relative expression was
118 and 193% for main effect of control and nCrPic diets, respectively, p < 0.001) and AKT (relative
expression was 92 and 122% for main effect of control and nCrPic diets, respectively, p = 0.08), but had
no effect in IR (p = 0.71) and GLUT4 (p = 0.97) mRNA expression. The expression of SOCS3 in skeletal
muscle tissue was lower in nCrPic pigs (relative expression was 105 and 89% for main effect of control
and nCrPic diets, respectively, p = 0.02).
3.6. UCP3, IL-15 and JNK1 Gene Expression in Porcine Skeletal Muscle Tissue
The expression of UCP3 mRNA tended to be higher in skeletal muscle in nCrPic animals (relative
expression was 90 and 124% for main effect of control and nCrPic diets, respectively, p = 0.082).
Similarly, the expression of interleukin-15 (IL-15) in skeletal muscle tissue tended to be higher in nCrPic
animals (relative expression was 93 and 134% for main effect of control and nCrPic diets, respectively,
p = 0.083). The expression of JNK1 tended to be decreased by dietary nCrPic (relative expression was
122 and 88% for main effect of control and nCrPic diets, respectively, p = 0.082) (Figure 4). A MANOVA
of the changes in the expression of all eight genes in skeletal muscle indicated an overall significant
effect of nCrPic (p = 0.042) and a trend for an effect of dietary fat (p = 0.094).
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3.7. Correlations between mRNA Expression and Phenotypic Parameters
The correlation coefficients between the ∆CT for each gene and each other as well as phenotypic
measures such as plasma HOMA and carcass back fat, loin muscle depth and carcass weight are
provided as supplemental material (Table S3) because of complexity. As expected there were a number
of significant correlations between the mRNA expression of related genes consistent with the effects of
dietary nCrPic and fat. With respect to the phenotypic measures, there were a number of significant
relationships with mRNA expression. For example, the ∆CT for adipose tissue ATK was positively
associated with HOMA (r = 0.56, p = 0.024) and negatively associated with skeletal muscle JNK1
(r = −0.43, p < 0.10). (Table S3). A positive association means that the phenotypic parameter decreases
as the gene mRNA expression increases and vice versa. Loin skeletal muscle depth was positively
related to adipose tissue TNFα (r = 0.51, p = 0.043), PPARγ (r = 0.53, p = 0.036) and GLUT4 (r = 0.58,
p = 0.018) and negatively associated with adipose tissue FAS (r = −0.52, p = 0.040) and skeletal muscle
IRS (r = −0.58, p = 0.019) and PI3K (r = −0.58, p = 0.020). Backfat depth was positively associated with
adipose tissue PI3K (r = 0.67, p = 0.005) and AKT (r = 0.56, p = 0.026) and negatively associated with
adipose tissue leptin (r = −0.51, p = 0.044) and SREBP (r = −0.56, p = 0.024) and skeletal muscle SOCS3
(r = −0.50, p = 0.046) and JNK1 (r = −0.57, p = 0.021).
4. Discussion
The essential trace mineral Cr has been suggested to have beneficial effects in individuals with
type 2 diabetes as evidenced by enhance insulin sensitivity and glucose transport at the molecular
level [4,28–30]. Dietary Cr can attenuate visceral fat accumulation and hence maintains healthy body
composition in diabetic and overweight individuals [23,31]. However, the underlying mechanism
by which Cr exerts its effects on the regulation of the insulin signaling pathway remains unclear.
This study demonstrates that dietary nCrPic supplementation markedly increased PI3K and AKT
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expression in the muscle tissue and AKT in the subcutaneous adipose tissue indicating that dietary
nCrPic can improve insulin sensitivity. These responses were associated with increased muscle mass
and reduced subcutaneous fat accumulation.
In muscle tissue, SOSC3 gene expression was down-regulated by dietary nCrPic supplementation.
The members of SOCS family, especially SOCS3 have been implicated in cytokine-mediated inhibition
of insulin signaling in adipose tissue, liver, and brain [32]. Furthermore, in skeletal muscle, SOCS3 is
up-regulated after high-fat feeding or by IL-6 stimulation [33–35]. Over-expression of SOCS3 has also
been shown to prevent leptin activation of AMPK signaling [34]. Therefore, elevated expression of
SOCS3 in skeletal muscle may impair AMPK modulation of insulin-mediated glucose uptake [33,34].
Moreover, SOCS3 can bind to tyrosine-phosphorylated IRS1 and target IRS1 degradation via the SOCS
box-mediated proteasomal complex [36]. In the present study, we found that both PI3K and AKT in
muscle tissue were up-regulated by dietary nCrPic supplementation. These results indicated that the
improvement of insulin sensitivity may be due to, at least in part, the reduction in SOCS3.
The maintenance of plasma glucose homeostasis is a complex process involving responsiveness of
several genes. The correct responses of IRS-PI3K-AKT are crucial for maintenance of insulin sensitivity.
Serine phosphorylation of IRS1 can decrease IRS1 activity, due to conformational changes, causing IRS1
to be unable to associate with IR [37]. The most important role of IRS1 is to bind and activate PI3K.
The gene PI3K is a key mediator of insulin signaling. The tyrosine phosphorylated IRS1 can activate
PI3K through interacting with PI3K regulatory subunit p85. Activated PI3K generates the second
messenger PIP3 which can activate AKT through phosphorylation. The activation of AKT facilitates
translocation of GLUT4 to the sarcolemma to facilitates glucose uptake into the cell [38]. In the present
study, skeletal muscle PI3K and AKT mRNA expression were up-regulated by nCrPic, indicating
that nCrPic can improve insulin sensitivity. Cefalu et al. [39] demonstrated that supplementation
of CrPic improves glucose disposal rates and enhances insulin-stimulated phosphorylation of IRS-1
and PI3K activity in skeletal muscle. The improvement of insulin signaling by Cr is associated with
the decrease of IRS-1 Ser307 phosphorylation [25,40]. Further, serine phosphorylation of IRS-1 is a
major target of JNK-mediated phosphorylation and elevated JNK phosphorylation occurs in insulin
resistant cells in vitro. Elevated hepatic phospho-c-Jun has been observed in obese and insulin resistant
mice [41], while tyrosine phosphorylation of c-Jun was suppressed by supplementation with chromium.
Endoplasmic reticulum (ER) stress may play a role in the development of insulin resistance, and ER
stress can activate JNK which in turn suppresses insulin signaling [42]. The results from the present
experiment support these findings as JNK1 expression tended to be reduced in skeletal muscle of gilts
fed nCrPic, while Özcan et al. [41] showed that inhibition of JNK activity reversed the ER-induced
serine phosphorylation of IRS-1.
In the present study, UCP3 mRNA in skeletal muscle was increased by dietary nCrPic
supplementation. In an in vitro study, Qiao et al. found that Cr improves glucose uptake through
up-regulating the mRNA level of UCP3 in skeletal muscles [28]. UCP3 is another protein which is
important for maintaining insulin sensitivity [43]. The increased expression of UCP3 is associated with
increased carnitine palmitoyltransferase-1B, the enzyme associated with fatty acid oxidation [44,45].
Incomplete fatty acid oxidation can contribute to insulin resistance [46]. Gao et al. [47] also indicated
that free fatty acid can activate c-JUN-NH2-Terminal Kinase and increase IRS-1 serine phosphorylation.
Moreover, UCP3 also limits mitochondrial damage by suppression of lipid peroxidation and the
production of reactive oxygen species [44]. IL-15, which is highly expressed in skeletal muscle tissue,
has anabolic effects on skeletal muscle both in vivo and in vitro [48,49]. In adipocyte cultures, IL-15
also inhibited preadipocyte differentiation, and stimulated secretion of adiponectin from differentiated
adipocytes [50]. In the present study, nCrPic also increased both IL-15 in skeletal muscle and adiponectin
in subcutaneous adipose tissue. Additionally, administration of IL-15 resulted in an increasing of
glucose uptake in both C2C12 cell culture and rat skeletal muscle [51]. Therefore, IL-15 could potentially
stimulate adiponectin production by adipose tissue, which in turn may modulate skeletal muscle
glucose metabolism and insulin sensitivity.
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The effects of Cr on transcription factors are still unclear. Lien et al. [52] reported that 3T3-L1
preadipocytes cultured with 50 ppb CrPic exhibited decreased PPARγ expression. However, there was
no significant effect of dietary nCrPic supplementation on PPARγ expression in the present study. Gene
expression analysis in subcutaneous adipose tissue identified that dietary high-fat supplementation
up-regulated both PPARγ and C\EBPα. PPARγ is highly expressed in adipocytes and is involved
in adipocyte differentiation, lipid storage, and glucose homeostasis [53]. PPARγ can be considered
as the “master regulator” of adipogenesis, as no other factor can facilitate adipogenesis in the
absence of PPARγ [54]. The expression of C\EPBα occurs in the latter stages of the adipocyte
differentiation process and has been shown to induce the differentiation of a variety of fibroblastic cells
into adipocytes [55]. PPARγ and C\EBPα cooperate to promote adipocyte differentiation, including
adipocyte gene expression and insulin sensitivity [56]. Adipocytes also play a central role in maintaining
energy balance. In addition, adipocytes produce and secrete adipokines which are involved in the
insulin-signaling pathway [12,57]. In the present study, subcutaneous adipose tissue adiponectin
mRNA expression was decreased by the high-fat diet and increased by dietary nCrPic, suggesting
that nCrPic may able to reverse the high-fat-diet-induced defects in insulin signaling. Adiponectin is
considered to be a marker of inflammation with lower concentrations exhibited in both obese humans
and animal models of obesity/insulin resistance [58–60]. Several studies have shown a link between
low circulating adiponectin concentrations and insulin resistance [61,62]. Jain et al. [63] reported that
dietary Cr supplementation can lower blood glucose by elevating blood adiponectin in Zucker diabetic
obese rats. In an obese cp/cp rat study, adiponectin level was not affected by CrPic alone, but was
increased by a combination of CrPic and conjugated linoleic acid [64].
5. Conclusions
In conclusion, these data provide strong evidence that dietary nCrPic can improve insulin
sensitivity in pigs consuming a high-fat diet. In particular, the expression of the insulin-signaling
pathway genes PI3K and AKT were increased by dietary nCrPic. Furthermore, the expression of
SOCS3 in skeletal muscle, which can aggravate insulin resistance, was reduced by nCrPic. Dietary
nCrPic also increased UCP3 and IL-15 in skeletal muscle, both of which facilitate glucose metabolism.
In subcutaneous adipose tissue, the expression of adiponectin was up-regulated by dietary nCrPic.
These findings indicate the improvement in the insulin-signaling pathway by dietary nCrPic may be
via decreased SOCS3 and increased UCP3 and IL-15 in skeletal muscle, as well as increased adiponectin
in subcutaneous adipose tissue.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2615/10/9/1685/s1,
Table S1: Effect of dietary nano CrPic and dietary fat on mitogen-activated protein kinase-8 (JNK1), leptin,
adiponectin, tumor necrosis factor α (TNFα), peroxisome proliferator-activated receptor γ (PPARγ), CCAAT
enhancer binding protein α (C/EBPα), sterol regulatory element-binding protein (SREBP), fatty acid synthase
(FAS), insulin receptor (IRS), phosphatidylinositol 3 kinase (PI3K), protein kinase B (AKT), uncoupling protein 3
(UCP3), suppressor of cytokine signaling 3 (SOCS3) and glucose transporter 4 (GLUT4) and mRNA expression in
subcutaneous adipose tissue from gilts, Table S2: Effect of dietary nano CrPic and dietary fat on interleukin-15
(IL-15), insulin receptor (IRS), phosphatidylinositol 3 kinase (PI3K), suppressor of cytokine signaling 3 (SOCS3),
uncoupling protein 3 (UCP3), protein kinase B (AKT), mitogen-activated protein kinase-8 (JNK1) and glucose
transporter 4 (GLUT4) mRNA expression in skeletal muscle tissue from gilts, Table S3: Correlations (r) between
mRNA expression (expressed as ∆CT) of adipose tissue mitogen-activated protein kinase-8 (JNK1), leptin,
adiponectin, tumor necrosis factor α (TNFα), peroxisome proliferator-activated receptor γ (PPARγ), CCAAT
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(FAS), insulin receptor (IRS), phosphatidylinositol 3 kinase (PI3K), protein kinase B (AKT), uncoupling protein
3 (UCP3), suppressor of cytokine signaling 3 (SOCS3) and glucose transporter 4 (GLUT4) and skeletal muscle
interleukin-15 (IL-15), IRS, PI3K, SOCS3, UCP3, AKT, JNK1 and GLUT4 and homeostatic model assessment
(HOMA), loin muscle depth, back fat depth and carcass weight in gilts.
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